Skip to main content
. Author manuscript; available in PMC: 2023 Jul 3.
Published in final edited form as: J Bone Miner Metab. 2020 Jan 25;38(4):544–554. doi: 10.1007/s00774-019-01081-1

Table 2.

Comparison of bone health at study entry in early COC users and other COC users

Variables at study entry Early COC use n = 8 COC use n = 26 P

Age (years)a 19.5 ± 0.7 19.2 ± 0.5 0.173
Body mass index (kg/m2)a 24.2 ± 3.8 23.2 ± 2.7 0.434
Years after menarche began COCa Bone sitesb (g/cm2) 2.9 ± 0.9 5.5 ± 1.0 < 0.001
 Anterior–posterior spine 0.972 ± 0.029 1.020 ± 0.016 0.151
 Lateral spine 0.745 ± 0.024 0.790 ± 0.013 0.105
 Femoral neck 0.835 ± 0.038 0.925 ± 0.021 0.048
 Total hip 0.934 ± 0.030 1.009 ± 0.017 0.035
 Whole body 1.007 ± 0.020 1.053 ± 0.011 0.050

P value for MANCOVA controlling for lean body mass at study entry, with Bonferroni correction

COC combined oral contraceptives, Early COC User women who began using COC medication ≤ 4 years menarche, COC Use women who began using COCs > 4 years after menarche

a

Means with standard deviations

b

Adjusted means with standard error